FRANK L. HURLEY is chief scientific officer at RRD International, LLC., with more than 30 years of experience in assisting companies with their regulatory, research and product development strategies. His expertise includes clinical trial design and analysis, review of preclinical and clinical information, preparation of regulatory documents, and presentations to government regulatory agencies. Dr. Hurley is a recognized published educator and an authority on research strategy and study design for pharmaceuticals, biologics, and medical devices. He co-founded BRI International, Inc. in 1971 and guided its growth as both chairman and chief scientific officer until he merged BRI with Quintiles Transnational, Inc. in 1996. Dr. Hurley served as chief scientific officer of Quintiles until 2001. He received a doctorate in biostatistics from the Johns Hopkins Bloomberg School of Public Health and a bachelor of science degree in mathematics and pre-medical sciences from Georgetown University.
|
